Asset Publisher

Sweden’s innovation agency Vinnova extends the funding of Genomic Medicine Sweden with additional SEK 36 million

Sweden’s innovation agency Vinnova extends the funding of Genomic Medicine Sweden with additional SEK 36 million

Sweden’s innovation agency Vinnova extends the funding of the national initiative Genomic Medicine Sweden (GMS) with an additional SEK 36 million in order to enable individualized healthcare solutions. The new technology allows more patients to receive the appropriate treatment at the right time. The collaboration between healthcare, industry and academia will contribute to strengthen Sweden´s position as an attractive country for innovation and clinical research writes Vinnova in the press release on July 2nd.

Genomic Medicine Sweden (GMS) was founded in 2018 with the aim of translating innovation in genomics into clinical practice and implementing a sustainable infrastructure for precision medicine in Sweden. CMM Group Leader Professor Richard Rosenquist Brandell is the Director of GMS.

Vinnova has continuously funded the GMS initiative, and now expands the funding by an additional SEK 36 million for the remaining of 2020 and all of 2021. Additional co-funding of SEK 52 million will also be added from the participating seven regions with University Hospitals, and the corresponding seven Universities Medical Faculties. The funding will continue to contribute to implementation of precision medicine into healthcare, and further strengthen Swedish research enabling new research and innovation collaborations between industry, healthcare and academia.

We congratulate Professor Richard Rosenquist Brandell and colleagues for their fantastic work, the additional funding to support GMS and the implementation of precision medicine in healthcare.

 

Richard Rosenquist Brandell                               

Professor of Clinical Genetics at the Department of Molecular Medicine and Surgery, Karolinska Institutet

Senior Physician in Clinical Genetics at Karolinska University Hospital

Group Leader CMM

 

Link to the Vinnova press release  2020-07-02

https://www.vinnova.se/nyheter/2020/06/precisionsmedicin-infors-i-halso--och-sjukvarden

Link to Genomic Medicine Sweden

https://genomicmedicine.se/

Link to news article in Dagens Medicin 2020-07-02

https://www.dagensmedicin.se/artiklar/2020/07/02/rekordstor-satsning-pa-precisionsmedicin/

A more detailed description of Richard Rosenquist Brandell’s research can be found on his CMM group page;

click here 

NEWS

Sweden’s innovation agency Vinnova extends the funding of Genomic Medicine Sweden with additional SEK 36 million

Sweden’s innovation agency Vinnova extends the funding of Genomic Medicine Sweden with additional SEK 36 million Sweden’s innovation agency Vinnova extends the funding of the national...

The Swedish Heart-Lung Foundation major grant 2020 goes to Marie Wahren-Herlenius

The Swedish Heart-Lung Foundation major grant 2020 goes to Marie Wahren-Herlenius Professor Marie Wahren-Herlenius, Group Leader at CMM, has received the biggest yearly grant in Sweden...

Simple blood test may help predict MS progression, study finds

Simple blood test may help predict MS progression, study finds Photo: Ali Manouchehrinia   A study led by the CMM researchers Ali Manouchehrinia (first...

Experimental study finds new substances with higher specificity and therapeutic potential in multiple sclerosis

Experimental study finds new substances with higher specificity and therapeutic potential in multiple sclerosis   Karl Carlström, photo Stefan Zimmerman   Karl...

Early exposure to cannabis boosts young brains' sensitivity to cocaine, rodent study shows

Early exposure to cannabis boosts young brains' sensitivity to cocaine, rodent study shows A study made by Philippe Melas from Karolinska Institutet together with colleagues at Columbia...

Grant to Eduardo Villablanca for studies of stem cell-mediated tissue regeneration in the intestine

Grant to Eduardo Villablanca for studies of stem cell-mediated tissue regeneration in the intestine Associate Professor Eduardo Villablanca, Group Leader at CMM, has received a Junior...

Anca Catrina, Wallenberg Clinical Scholar 2020

Anca Catrina, Wallenberg Clinical Scholar 2020 We congratulate our CMM researcher Professor Anca Catrina, Group Leader at Karolinska Institutet and senior physician, who has been appointed...

Junior Investigator Award to Carmen Gerlach

Junior Investigator Award to Carmen Gerlach Assistant Professor Carmen Gerlach, Team Leader at CMM, will receive funding during six years from the Swedish Cancer Society (Cancerfonden) for...

Proteins that protect against joint inflammation identified

Proteins that protect against joint inflammation identified " Endogenous proteins that play a vital part in allergies and parasitic infection can prevent the immune system from wrongly...

New study shows that Proprotein Convertase 6 plays a key role in vascular disease

New study shows that Proprotein Convertase 6 plays a key role in vascular disease In a new study published in Circulation Research, researchers at CMM show that the enzyme PCSK6, the...